Study on Prevention and Treatment of Dry Eye in Patients Using Glaucoma Drops
NCT03515187 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 160
Last updated 2018-05-03
Summary
A multicenter randomized controlled trial on prevention and treatment of ocular surface injury and meibomian gland dysfunction in patients using anti-glaucoma eye drops.
Conditions
- Dry Eye
- MGD-Meibomian Gland Dysfunction
Interventions
- DRUG
-
0.3% sodium hyaluronate ophthalmic solution
one to two drops in eye, four times per day
- DRUG
-
0.1% sodium bromide solution
one to two drops in eye, twice per day
- OTHER
-
Meibomian gland massage
Physiotherapy
- OTHER
-
Placebo
Vehicle
Sponsors & Collaborators
-
Shenzhen Hospital of Southern Medical University
lead OTHER
Principal Investigators
-
Yingli Li · Shenzhen Hospital of Southern Medicine University
-
Min Fu · Zhejiang Hospital
-
Lang Bai · Nanfang Hospital, Southern Medical University
-
Guanghua Zhou · The Fifth Affiliated Hospital of Southern Medical University
-
Lei Xi · Guangdong Provincial People's Hospital
-
Xiaolin Zhao · Shenzhen Hospital of Southern Medicine University
-
Wanli Liu · Shenzhen Hospital of Southern Medicine University
-
Yan Wang · Shenzhen Hospital of Southern Medicine University
-
Lina Chen · Shenzhen Hospital of Southern Medicine University
-
Sijing Zhang · Shenzhen Hospital of Southern Medicine University
-
Shingle An · Southern Medicine University
-
Liang Zhang · Guangdong Provincial People's Hospital
-
Ting Meng · Zhejiang Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-06-30
- Primary Completion
- 2021-04-30
- Completion
- 2021-10-31
Countries
- China
Study Locations
More Related Trials
-
Efficacy and Safety of SJP-0132 Eye Drops in Chinese Patients With Dry Eye Disease
NCT06717152 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy Comparison of Two Kinds of Treatment in Treating Dry Eye Caused by Meibomian Gland Dysfunction
NCT02958514 ·Status: COMPLETED ·Phase: NA
-
A Study Evaluating the Efficacy and Safety on Moderate to Severe Dry Eye
NCT04092907 ·Status: COMPLETED ·Phase: PHASE2
-
Brimonidine Eye Drops for Treatment of Ocular Graft-vs-Host Disease (oGVHD)
NCT02975557 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
YM-101 Eye Drops in the Treatment of Dry Eye Syndrome
NCT06792903 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Evaluation of Meibomian Gland Dysfunction in Chinese Old Patients
NCT02481167 ·Status: UNKNOWN
-
A Randomized Study of Smile Exercise for Dry Eye
NCT04421300 ·Status: COMPLETED ·Phase: NA
-
Efficacy of 0.38% and 0.18% Sodium Hyaluronate Ocular Lubricants for Dry Eye in Adult Gazan Participants
NCT06851364 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Tolerability of Artificial Tears in Dry Eye Subjects
NCT00932477 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate the Efficacy and Safety of Treatment With CsA-PG Ophthalmic Gel in Dry Eye Patients
NCT06942793 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Study to Compare the Efficacy and Safety of Two Non-Preserved Artificial Tears for the Treatment of Dry Eye Signs and Symptoms
NCT00938704 ·Status: COMPLETED ·Phase: PHASE4
-
A Randomized, Parallel-Group Comparison Study of Topical Corticosteroids in Dry Eye Patients With Sjögren Syndrome
NCT02011776 ·Status: COMPLETED
-
Comparing the Quality of Topical Autologous Serum in Different Etiologies of Dry Eye Syndrome
NCT02774707 ·Status: UNKNOWN
-
Pharmacokinetics, Safety, and Tolerability of rhEGF Eye Drops in Healthy Male Subjects
NCT05219461 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of SHR8028 Eye Drops for the Treatment of Dry Eye Disease
NCT05841043 ·Status: COMPLETED ·Phase: PHASE3
-
Microvascular and Inflammatory Responses of 0.05 Cyclosporine Eye Drop (II) in Treatment of Dry Eye
NCT05131152 ·Status: UNKNOWN ·Phase: NA
-
Efficacy of 20% Autologous Serum Drops in the Treatment of Corneal Epitheliopathy Associated With Antihypertensive Glaucoma Drops.
NCT06294015 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Evaluate the Tolerance, Safety and Pharmacokinetics of Germinal Peptide Eye Drops in Healthy Volunteers
NCT03662971 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of Therapeutic Effect of Bandage Contact Lenses ( BCL) on Dry Eye Caused by Sjogren's Syndrome
NCT02147509 ·Status: COMPLETED ·Phase: NA
-
Safety, Efficacy, Tolerability and Pharmacokinetics of AGN-223575 Ophthalmic Suspension in Patients With Dry Eye Disease
NCT02435914 ·Status: COMPLETED ·Phase: PHASE2
-
Correlation of Dry Eye Disease, Problematic Smartphone Use and Sleep Quality in Adolescents and Young Adults
NCT07020871 ·Status: NOT_YET_RECRUITING
-
Study of SY-201 Ophthalmic Solution in Subjects With Dry Eye Disease
NCT05370495 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study to Confirm the Efficacy and Safety of K-161 Ophthalmic Solution for Treatment of Moderate to Severe Dry Eye Disease
NCT05403827 ·Status: COMPLETED ·Phase: PHASE3
-
Assess the Safety and Efficacy of CsA Ophthalmic Gel in Subjects With Dry Eye
NCT03676335 ·Status: COMPLETED ·Phase: PHASE2
-
To Evaluate the Short-term and Long Term Efficacy of Acupuncture in Ocular and Oral Dryness Symptoms of Dry Eye Syndrome
NCT04877483 ·Status: UNKNOWN ·Phase: NA